Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of facial paralysis
3.2.1.2 Rising awareness for early screening and diagnosis
3.2.1.3 Growing demand for facial reanimation surgeries
3.2.1.4 Availability of advanced therapeutical treatment options
3.2.2 Industry pitfalls & challenges
3.2.2.1 High treatment cost
3.2.2.2 Potential complications and risks associated with surgical treatments
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Bell's palsy
5.3 Acquired facial palsy
5.4 Congenital facial palsy
Chapter 6 Market Estimates and Forecast, By Management Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Treatment
6.2.1 Medication
6.2.2 Physical therapy
6.2.3 Surgical intervention
6.3 Diagnosis
6.3.1 Electromyography device
6.3.2 Magnetic resonance imaging (MRI)
6.3.3 Computed tomography scan
Chapter 7 Market Estimates and Forecast, By End User, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Specialty clinics
7.5 Diagnostic centers
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 UAE
8.6.3 Saudi Arabia
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Brainlab AG (Dr. Langer Medical GmbH)
9.2 GE Healthcare
9.3 GlaxoSmithKline plc
9.4 iTENS Australia
9.5 Johnson & Johnson Services, Inc.
9.6 MED-EL Medical Electronics
9.7 Medtronic plc
9.8 Natus Medical
9.9 Nihon Kohden Corporation
9.10 Novartis AG
9.11 Pfizer Inc.
9.12 Sanofi
9.13 Siemens Healthineers AG
9.14 TensCare Ltd.
9.15 Teva Pharmaceutical Industries Ltd.
